Current medical therapy for acute pancreatitis is supportive care... NPO, IV fluid and pain management... These patients come in the ER and get the typical supportive care, imaging and labs... then gets admitted until the symptoms improve. The ER physicians and admitting attending physicians have NO other treatment options besides the supportive care pathway.
Proehl stated yesterday at the BoA conference that currently Ruconest is indicated to treat hereditary angioedema.. SNTS is planning on two other indications.. 1. Prophylatic treatment of HAE and 2. Treatment of Acute Pancreatitis.
There is no FDA approved product currently to treat acute pancreatitis which is a huge disease area.. There over 30 causes of acute pancreatitis, mostly alcohol and gallstone induced (we love our drinks and fatty food)... typical ER will see several acute pancreatitis patients per day...
If SNTS can demonstrate efficacy in treating pancreatitis in the acute setting with Ruconest, there will be huge upside potential here!!!! SNTS is a superstar!!